Quantifying Hepatic Mitochondrial Fluxes in Humans
Conditions: Non-Alcoholic Fatty Liver Disease; Type 2 Diabetes; Mitochondrial Metabolism Disorders Interventions: Drug: Pioglitazone; Other: Placebo Sponsor: The University of Texas Health Science Center at San Antonio Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Actos | Diabetes | Endocrinology | Mitochondrial Disease | Research | Science | Texas University